Over 500 excess deaths a week involving heart diseases have been documented since the onset of the COVID-19 pandemic, according to the British Heart Foundation (BHF).
The BHF’s report, based on data from the Office for Health Improvement and Disparities, found that there’s been a total of 96,540 excess deaths involving cardiovascular conditions like heart attacks and strokes since February 2020.
“It is deeply troubling that so many more people with cardiovascular disease have lost their lives over the past three years,” BHF Chief Executive Dr. Charmaine Griffiths said Thursday.
“For years now, it has been clear that we are firmly in the grip of a heart and stroke care emergency. If little changes, we could continue to see a sustained rise in death rates from cardiovascular conditions that undoes decades of scientific progress to reduce the number of people who die of a heart attack or stroke.”
“There is no time to waste – Government must take control of this crisis to give heart patients and their loved ones hope of a better and healthier future,” she added.
The paper also cited a separate study outlining how those who were infected with COVID before the vaccine rollout were five times more likely to die in the 18 months after infection.
Consultant cardiologist Dr. Sonya Babu-Narayan highlighted how COVID-19 deaths have been steadily falling while cardiovascular deaths keep rising.
“Covid-19 no longer fully explains the significant numbers of excess deaths involving cardiovascular disease,” she claimed. “Other major factors are likely contributing, including the extreme and unrelenting pressure on the NHS over the last few years.”
But notably, the BHF report downplayed the risks posed by the experimental COVID mRNA injections, claiming myocarditis cases have been “rare.”
“COVID-19 vaccine associated myocarditis has been rare, more common in young men after a second vaccine dose, and fortunately shows a favourable clinical course in the vast majority of those affected,” the study claimed.
“The benefits of receiving COVID-19 vaccines in reducing severe outcomes from COVID-19 infection in people living with cardiovascular disease greatly outweigh the risk of extremely rare side effects,” it stated.
Read the BHF report: